NOVA por http://www.unicolmayor.edu.co/publicaciones/index.php/nova se distribuye bajo una licencia Reconocimiento No Comercial- Compartir igual
Así mismo, los autores mantienen sus derechos de propiedad intelectual sobre los artículos,
Declaración de privacidad.
Los nombres y las direcciones de correo electrónico introducidos en esta revista se usarán exclusivamente para los fines establecidos en ella y no se proporcionarán a terceros o para su uso con otros fines.
Comparison in the Handling of Patients With Mitral Mixomatosa Degeneration With Enalapril or With the Combination Enalapril Spironolactone
It was observed that aldosterone has a reduction in the serum levels subsequent to the treatment with enalapril and espironolactona far beyond the treated solely with enalapril, but in the last evaluation, they increase the levels over the initial values, which suggests they already have activated other routes for the synthesis from the aldosterone, which are not mediated by angiotensin II and therefore they do not respond suitably to converter enzymes of angiotensin. The benefit of the combination with espironolactone is based on its selective blocking a selective of the aldosterone receivers, which would diminish its lethal action on the myocardium and the blood vessels.
How to Cite
